Announcements
- Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION
- Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN
- Hofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORT
- Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activity
- Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED
- Hofseth Biocare ASA: EXTRAORDINARY GENERAL MEETING CONCLUDED
- Hofseth Biocare ASA: EGM Notice Correction
- Hofseth Biocare ASA: Notice of an extraordinary general meeting
- Hofseth Biocare ASA: SIGNIFICANT NEW INVESTMENT OF NOK 144 MILLION FROM HOFSETH INTERNATIONAL INTO HBC
- Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING
More ▼
Key statistics
As of last trade Hofseth Biocare ASA (0Q6H:LSE) traded at 2.16, 0.00% above its 52-week low of 2.16, set on Mar 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 2.16 |
Average volume | 399.00 |
---|---|
Shares outstanding | 395.08m |
Free float | 164.87m |
P/E (TTM) | -- |
Market cap | 821.77m NOK |
EPS (TTM) | -0.270 NOK |
Data delayed at least 20 minutes, as of Mar 15 2024 11:47 BST.
More ▼